EXAS vs OLN · rev $2.76B vs rev $6.54B
EXACT Sciences Corporation (EXAS) versus Olin Corporation (OLN) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Olin Corporation (OLN) is a chemicals company listed on NYSE.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported OLN revenue for 2024-12-31 was $6.54B. Net income was $105.0M. Revenue was down 4.3% from 2023-12-31 to 2024-12-31. OLN currently screens at market cap $2.62B.
EXAS currently screens at market cap $20.03B. OLN currently screens at market cap $2.62B.
Not investment advice. Open the EXAS and OLN stock pages for the full models.
Not investment advice.